Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,922 | 15,101 | 111,116 | 43,191 | 47,422 |
| Marketable Securities | 88,322 | 91,640 | N/A | N/A | N/A |
| Receivables | 657 | 464 | 2,593 | 250 | 215 |
| TOTAL | $99,474 | $108,934 | $115,680 | $44,031 | $49,057 |
| Non-Current Assets | |||||
| PPE Net | 1,070 | 1,263 | 1,517 | 1,710 | 1,897 |
| Other Non-Current Assets | 1,469 | 700 | 700 | 700 | 700 |
| TOTAL | $2,539 | $1,963 | $2,217 | $2,410 | $2,597 |
| Total Assets | $102,013 | $110,897 | $117,897 | $46,441 | $51,654 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | 6,089 | 5,268 | 3,374 | 3,150 | 2,464 |
| TOTAL | $6,089 | $5,268 | $3,374 | $3,239 | $3,427 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 89 | 963 |
| Other Non-Current Liabilities | 997 | 585 | 660 | 732 | 803 |
| TOTAL | $997 | $585 | $660 | $732 | $803 |
| Total Liabilities | $7,086 | $5,853 | $4,034 | $3,971 | $4,230 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 757 | 757 | 756 | 754 | 634 |
| Common Shares | 27 | 27 | 27 | 23 | 23 |
| Retained earnings | -115,583 | -104,891 | -95,361 | -90,574 | -84,890 |
| Other shareholders' equity | 4 | -35 | 0 | 0 | 0 |
| TOTAL | $94,927 | $105,044 | $113,863 | $42,470 | $47,424 |
| Total Liabilities And Equity | $102,013 | $110,897 | $117,897 | $46,441 | $51,654 |